| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute interstitial nephritis associated with moxifloxacin use
|
Argirov, Michael
|
|
2005
|
27 |
8 |
p. 1260-1263
4 p.
|
artikel
|
| 2 |
A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged ≥65 years with community-acquired pneumonia
|
Shorr, Andrew F.
|
|
2005
|
27 |
8 |
p. 1251-1259
9 p.
|
artikel
|
| 3 |
An open-label, noncomparative study of miglustat in type I Gaucher disease: Efficacy and tolerability over 24 months of treatment
|
Pastores, Gregory M.
|
|
2005
|
27 |
8 |
p. 1215-1227
13 p.
|
artikel
|
| 4 |
A pooled comparison of cefdinir and penicillin in the treatment of group a β-hemolytic streptococcal pharyngotonsillitis
|
Brook, Itzhak
|
|
2005
|
27 |
8 |
p. 1266-1273
8 p.
|
artikel
|
| 5 |
A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemia
|
Wilson, Alexandria Garavaglia
|
|
2005
|
27 |
8 |
p. 1228-1237
10 p.
|
artikel
|
| 6 |
Cardiovascular safety of lumiracoxib: A meta-analysis of all randomized controlled trials ≥1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis
|
Matchaba, Patrice
|
|
2005
|
27 |
8 |
p. 1196-1214
19 p.
|
artikel
|
| 7 |
Clinical applications of exhaled nitric oxide for the diagnosis and management of asthma: A consensus report
|
Zitt, Myron
|
|
2005
|
27 |
8 |
p. 1238-1250
13 p.
|
artikel
|
| 8 |
Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom
|
De Cock, Erwin
|
|
2005
|
27 |
8 |
p. 1295-1310
16 p.
|
artikel
|
| 9 |
Development and validity testing of the neuropathy total symptom score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy
|
Bastyr III, Edward J.
|
|
2005
|
27 |
8 |
p. 1278-1294
17 p.
|
artikel
|
| 10 |
Duloxetine hydrochloride: A new dual-acting medication for the treatment of major depressive disorder
|
Hunziker, Melanie E.
|
|
2005
|
27 |
8 |
p. 1126-1143
18 p.
|
artikel
|
| 11 |
Muraglitazar, a dual (α/γ) PPAR activator: A randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes
|
Buse, John B.
|
|
2005
|
27 |
8 |
p. 1181-1195
15 p.
|
artikel
|
| 12 |
Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues
|
Rolla, Arturo R.
|
|
2005
|
27 |
8 |
p. 1113-1125
13 p.
|
artikel
|
| 13 |
Telithromycin: The first ketolide antimicrobial
|
Nguyen, Megan
|
|
2005
|
27 |
8 |
p. 1144-1163
20 p.
|
artikel
|
| 14 |
The authors' reply
|
FitzGerald, J. Mark
|
|
2005
|
27 |
8 |
p. 1311-1315
5 p.
|
artikel
|
| 15 |
The visibility and divisibility of quality-adjusted life-years
|
Mullins, C. Daniel
|
|
2005
|
27 |
8 |
p. 1276-1277
2 p.
|
artikel
|
| 16 |
Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial
|
Vinik, Aaron I.
|
|
2005
|
27 |
8 |
p. 1164-1180
17 p.
|
artikel
|
Tijdschrift beschrijving